세계의 니티놀 의료기기 시장(2023-2030년)

Overview

Nitinol is an equiatomic metal alloy of nickel and titanium with unique properties, including superelasticity or pseudoelasticity and shape memory. Nitinol's superelastic properties allow medical devices using it to compress to a lower profile. Implants made of nitinol such as heart valves expand to their intended size and shape at the site of implantation and remain inside the patient.

Cardiovascular devices like stents, heart valves, guidewires, and vena cava filters have frequently uses nitinol. The use of nitinol in other device areas is growing particularly for products intended for use in minimally invasive procedures.

Market Dynamics

Increasing product launches

Nitinol is commonly used in manufacturing medical device due to its high thermal conductivity and biocompatibility. The increasing number of product launches for nitinol medical devices acts as a significant driver for market growth. Also, many key players play a major role in the advancements of the market by launching new treatment devices.

For instance, in May 2022, Stryker launched its EasyFuse Dynamic Compression System created by using nitinol, a nickel-titanium alloy metal well known for its strength and shape recovery.

Also, in February 2022, Medline UNITE Foot & Ankle Division launched the REFLEX Nitinol Dynamic Disc System at the American College of Foot & Ankle Surgeons (ACFAS) Annual Scientific Conference.

Additionally, in May 2021, Medline launched the REFLEX Nitinol Staple System. By enhancing surgical efficiency and improving implant strength, this staple is intended to improve patient outcomes.

Furthermore, significant growth drivers such as the rising prevalence and incidence of chronic diseases, and the growing adoption of minimally invasive surgeries by using nitinol medical devices are expected to drive the market in the forecast period.

Availability of alternative metals

The availability of other metals can hamper the market growth. Medical devices can also be made from biomaterial metals like stainless steel and cobalt-chromium alloys because they are less expensive than nitinol, and also copper-based alloys are more also frequently used in the manufacturing of medical devices.

Segment Analysis

The global nitinol medical devices market is segmented based on device type, application, end users and region.

Nitinol Stents Accounted for Approximately 46.7% of the Market Share

Nitinol stent is shaped like a trumpet that allows excellent conformability to vessel anatomy and is designed for bifurcation lesions. Nitinol Stents are expected to hold the largest market share over the period forecast owing to increasing new nitinol stents launches and technical advancements.

For instance, in August 2022, Medtronic launched its new interventional offering for coronary artery disease (CAD) called Onyx Frontier drug-eluting stent (DES) which is designed to have an updated delivery system, improved flexibility, and lower crossing profile.

Additionally, in January 2022, Cook Medical received Breakthrough Device designation approval from the U.S FDA on a new drug-eluting stent for below the knee. This stent is used to treat patients suffering from chronic limb-threatening ischemia.

Geographical Analysis

North America is expected to hold a significant position in the global nitinol medical devices market share

The global nitinol medical devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising incidence of medical surgery procedures, and increasing product launches, this trend is anticipated to continue throughout the forecast period.

For instance, according to the HexaHealth report published in 2023, around 4,00,000 heart bypass surgeries are performed every year, and approximately 2,00,000 surgeries are performed in the United States. Hence, there is an increased demand for nitinol catheters and guidewires to be utilized in heart surgeries and help in the market growth.

According to the American Joint Replacement Registry (AJRR) 2022. The annual report of hip and knee replacement demonstrates an overall cumulative procedural volume growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, and ambulatory surgery centers (ASCs). Hence, there is an increased demand for nitinol medical implants that can be used in arthroplasty procedures.

Additionally, in September 2020, MedShape, Inc. launched the DynaClip Forte Nitinol Bone Fixation System. It has a four-legged inline design and uses superelastic nickel-titanium (NiTiNOL) technology to match the mechanical and anatomical specifications of various high load-bearing applications, like tarsometatarsal (Lapidus) fusion.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the global nitinol medical devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the nitinol medical devices market is expected to be moderately affected over the forecast period.

Competitive Landscape

The major global players in the market include: Medtronic Plc., Arthrex Inc., B. Braun Melsungen AG, Cook Medical Inc., Zimmer Biomet Holdings Inc., Terumo Medical Corporation, Boston Scientific Corporation, Abbott Laboratories, Endosmart GmbH, W. L. Gore & Associates Inc. among others.

Key Developments

• In October 2023, Resonetics closed its $900 million acquisition of the SAES Getters medical nitinol business. The Smart Materials business creates raw nitinol alloys from nickel and titanium and produces nitinol wires, bars, ribbons, and sheets.
• In March 2023, Medtronic received a CE Mark for the Affera Mapping and Ablation System, which includes the Sphere-9 Catheter and the Affera Prism-1 Mapping Software. With its 9mm Nitinol ablation tip, the all-in-one catheter can treat fewer focal ablation lesion administrations.
• In April 2021, DJO acquired MedShape, Inc., where it uses its unique superelastic nickel-titanium form memory alloy and shape memory polymer technology to offer cutting-edge surgical solutions for foot and ankle surgeons.

Why Purchase the Report?

• To visualize the global nitinol medical devices market segmentation based on device type, application, end users, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of nitinol medical devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global nitinol medical devices market report would provide approximately 61 tables, 64 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Device Type
• 3.2. Snippet by Application
• 3.3. Snippet by End Users
• 3.4. Snippet by Region

4. Market Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing product launches
    • 4.1.1.2.
  • 4.1.2. Restraints
    • 4.1.2.1. Availability of alternative metals
    • 4.1.2.2.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 7.1.2. Market Attractiveness Index, By Device Type
• 7.2. Nitinol Staples*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Nitinol Stents
• 7.4. Nitinol Guidewires
  • 7.4.1. Orthodontic Guidewires
  • 7.4.2. Endoscopic Guidewires
• 7.5. Nitinol Filters
• 7.6. Nitinol Basket
• 7.7. Nitinol Catheters

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Orthopedic*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Urology
• 8.4. Vascular
• 8.5. Dental
• 8.6. Gastroenterology
• 8.7. Others

9. By End Users

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 9.1.2. Market Attractiveness Index, By End Users
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic Plc.
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Arthrex Inc.
• 12.3. B. Braun Melsungen AG
• 12.4. Cook Medical Inc.
• 12.5. Zimmer Biomet Holdings Inc.
• 12.6. Terumo Medical Corporation
• 12.7. Boston Scientific Corporation
• 12.8. Abbott Laboratories
• 12.9. Endosmart GmbH
• 12.10. W. L. Gore & Associates Inc.

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us